Insider Trading: Aceto Corp (ACET.O)
ACET.O on Nasdaq
11.86USD
20 May 2013
11.86USD
20 May 2013
Price Change (% chg)
$0.30 (+2.60%)
$0.30 (+2.60%)
Prev Close
$11.56
$11.56
Open
$11.54
$11.54
Day's High
$12.08
$12.08
Day's Low
$11.50
$11.50
Volume
243,403
243,403
Avg. Vol
108,955
108,955
52-wk High
$12.08
$12.08
52-wk Low
$7.90
$7.90
EILENDER ALBERT L
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 23 Aug 2012 | Buy | 10,125 | $0.00 | 115,731 |
| 1 Jul 2012 | Buy | 15,000 | $9.11 | 105,606 |
| 24 Nov 2011 | Buy | 25,000 | $5.89 | 90,606 |
| 27 Sep 2011 | Buy | 6,750 | $2.91 | 65,606 |
| 2 Aug 2011 | Buy | 7,500 | $6.18 | 58,856 |
Institutional Holders
| % Shares Owned: | 71.59% |
| # of Holders: | 119 |
| Total Shares Held: | 19,611,868 |
| 3 Mo. Net Change: | 938,407 |
| # New Positions: | 9 |
| # Closed Positions: | 13 |
| # Increased Positions: | 57 |
| # Reduced Positions: | 52 |
| # Net Buyers: | 5 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Albert Eilender |
69 | 2013 | Chairman of the Board |
Salvatore Guccione |
49 | 2013 | President, Chief Executive Officer, Chief Operating Officer, Director |
Douglas Roth |
55 | 2010 | Chief Financial Officer, Senior Vice President |
Steven Rogers |
51 | 2011 | Senior Vice President, General Counsel, Corporate Secretary |
Charles Alaimo |
46 | 2012 | Senior Vice President - Human Resources |
Raymond Bartone |
50 | 2012 | Senior Vice President - Nutritionals |
Frank DeBenedittis |
58 | 2011 | Senior Vice President - Corporate Business Development |
David Rosen |
54 | 2012 | Senior Vice President - Business Development |
Nicholas Shackley |
48 | 2011 | Senior Vice President - Pharmaceutical Ingredients |
Roger Weaving |
53 | 2010 | Senior Vice President - Performance Chemicals |
Guillaume Saint-Clair |
41 | 2011 | Vice President - Pharmaceutical Intermediates Business |
Jan Van Eis |
54 | 2010 | Vice President - Active Pharmaceutical Ingredients and Emerging Markets |
Ronald Gold |
53 | 2010 | President and Chief Operating Officer of Rising Pharm |
Lukas von Hippel |
51 | 2011 | Managing Director, Pharma Waldhof GmbH |
Hans Noetzli |
71 | 2009 | Lead Independent Director |
Natasha Giordano |
52 | 2010 | Director |
William Britton |
67 | 2006 | Independent Director |
Richard Randall |
74 | 2009 | Independent Director |
Robert Wiesen |
61 | 1994 | Independent Director |
Amy Glynn |
IR Officer |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
